Shaanxi Meibang Pharmaceutical Group Co., Ltd. / Fundamentals
Income statement
- Net revenue
€103.74M - Cost of goods sold
€74.09M - Gross profit
€29.66M - SG&A expenses
€13.40M - R&D expenses
€9.32M - EBITDA
€3.54M - D&A
€665.40K - EBIT
€642.08K - Interest expenses
€19.77K - EBT
€2.34M - Tax expenses
-€358.49K - Net income
€2.69M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€15.58M - Changes in working capital
-€14.83M - Operating cash flow
€14.77M - Capex
€19.59M - Other investing cash flow
€271.20K - Net investing cash flow
-€27.14M - Total cash dividends paid
-€3.40M - Issuance of common stock
€0.00 - Debt repayment
€8.67M - Other financing cash flow
-€4.37M - Net financing cash flow
€901.31K - Foreign exchange effects
€0.02 - Net change in cash
-€4.46M - Cash at end of period
€19.50M - Free cash flow
€34.36M
Balance sheet
- Cash and cash equivalents
€28.84M - Cash and short-term investments
€59.56M - Total receivables
€20.77M - Inventory
€27.20M - Other current assets
€12.78M - Total current assets
€120.31M - Property, plant & equipment
€76.26M - Goodwill
€0.00 - Intangible assets
€14.16M - Long-term investments
€0.24 - Other non-current assets
€8.24M - Total non-current assets
€100.42M - Total assets
€220.73M - Accounts payable
€42.18M - Short-term debt
€0.00 - Other current liabilities
€17.00M - Total current liabilities
€59.35M - Long-term debt
€8.67M - Deferred tax liabilities
€547.85K - Other non-current liabilities
€12.71M - Total non-current liabilities
€22.31M - Total liabilities
€81.66M - Common stock
€16.28M - Retained earnings
€64.02M - Other equity
€0.00 - Total equity
€139.07M - Total liabilities and shareholders' equity
€220.73M
Company information
- Market capitalization
€318.83M - Employees
939 - Enterprise Value
€2.85B
Company ratios
- Gross margin
-
28.6% Better than peer group: 22.2% - EBITDA margin
-
3.4% Worse than peer group: 11.9% - EBIT margin
-
0.6% Worse than peer group: 8.1% - EBT margin
-
2.3% Worse than peer group: 8.2% - Net margin
-
2.6% Even with peer group: 7.0% - ROE
-
1.9% Worse than peer group: 8.0% - ROA
-
1.2% Even with peer group: 5.5% - Asset turnover
-
47.0% Much worse than peer group: 78.2% - FCF margin
-
-4.6% Even with peer group: -7.5% - FCF yield
-1.5% - Efficiency ratio
96.6% - Net sales per employee
-
€110.48K - Net income per employee
-
€2.87K